Kansanterveyslaitos KTL

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion

Staessen JA; Thijs L; O'Brien ET; Bulpitt CJ; De Leeuw PW; Fagard RH; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Safar ME; SYST-EUR Trial Investigators
AM J HYPERTENS (2002)

Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension

Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; De Leeuw PW; Efstratopoulus AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y; SYST-EUR Trial Investigators; Sarti C
Hypertension (1998)

Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project

Seux M-L; Thijs L; Forette F; Staessen JA; Birkenhäger WH; Bulpitt CJ; Girerd X; Jääskivi M; Vanhanen H; Kivinen P; Yodfat Y; Vänskä O; Antikainen R; Laks T; Webster JR; Hakamäki T; Lehtomäki E; Lilov E; Grigorov M; Janculova K; Halonen K; Kohonen-Jalonen P; Kermowa R; Nachev C; Tuomilehto J; on behalf of SYST-EUR Investigators; Sarti C
J Hypertens : 7 (1998)

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

Staessen JA; Thijs L; Fagard R; Celis H; Birgenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Forette F; Leonetti G; McCormack P; Nachev C; O'Brien E; Rodicio JL; Rosenfeld J; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Zanchetti A; TheSys-Eur Trial Investigators
J Hypertens (2004)

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension

Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; De Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R; The Systolic Hypertension in Europe (Syst-Eur) Trial Investi
J Hypertens (2001)

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-up Study (SYST-EUR 2)

Thijs L; Staessen JA; Beleva S; Birkenhäger WH; Bulpitt CJ; Celis H; Fletcher AE; Kermova R; Leonetti G; Laks T; Mantov S; Nachev C; Sarti C; Tuomilehto J; Fagard RH; Systolic Hypertension in Europe Investigators
Current Controlled Trials in Cardiovascular Medicine : 6 (2001)

Hypertension in the very elderly trial (HYVET) protocol for the main trial

Bulpitt C; Fletcher A; Beckett N; Coope J; Gil-Extremera B; Forette F; Nachev C; Potter J; Sever P; Staessen J; Swift C; Tuomilehto J
DRUGS AGING (2001)

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial

Celis H; Thijs L; Staessen JA; Birkenhäger WH; Bulpitt CJ; De Leeuw PW; Leonetti G; Nachev C; Tuomilehto J; Fagard RH; Syst-Eur Investigators
J Hum Hypertens (2001)

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension

Staessen J; Thijs L; Fagard R; Clement D; De Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Systolic Hypertension in Europe Trial Investigators; Sarti C
JAMA : 6 (1999)

Predictive value of clinic and ambulatory heart rate for mortality in elderly subject with systolic hypertension

Palatini P; Thijs L; Staessen JA; Fagard RH; Bulpitt CJ; Clement DL; de Leeuw PW; Jääskivi M; Leonetti G; Nachev C; O'Brien ET; Parati G; Rodicio JL; Roman E; Sarti C; Tuomilehto J
Arch Intern Med (2002)

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Staessen JA; Fagard R; Thijs L; Arabidze GG; Birkenhänger WH; Bulpitt CJ; de Leeuw P; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A; for the Syst-Eur Trial Investigators; Sarti C
Lancet (1997)

Results of the pilot study for the hypertension in the very elderly trial

Bulpitt CJ; Beckett NS; Cooke J; Dumitrascu DL; Gil-Extremera B; Nachev C; Nunes M; Peters R; Staessen JA; Thijs L; on behalf of the Hypertension in the Very Elderly Trial (HYV
J Hypertens (2003)

Subgroup and Pre-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly

Staessen JA; Fagard R; Thijs L; Celis H; Birkenhager WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene M-R; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A; for the Systolic Hypertension in Europe Trial Investigators; Sarti C
Arch Intern Med (1998)

Systolic blood pressure variablilty as a risk factor for stroke adn cardiovascular mortality in the elderly hypertensive population

Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; De Leeuw PW; Jaaskivi M; Nachev C; Parati G; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH
J Hypertens (2003)

Systolic hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress

Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; De Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y; on behalf of Syst-Eur Investigators; Sarti C
J Hum Hypertens (1999)

Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trial

Antikainen R; Tuomilehto J; Thijs L; Vanhanen H; Sarti C; Birkenhäger W; Arabidze G; Fagard R; Grigorow M; Jankulova K; Jääskivi M; Kohonen-Jalonen P; Laks T; Lazebnic L; Mantova S; Nachev C; Kermova P; Vänskä O; Yodfat Y; Bulpitt CJ; Staessen JA; Syst-Eur investigators
J Hum Hypertens (1997)

Withdrawal from treatment in the SYST-EUR Trial

Bulpitt CJ; Beckett NS; Fletcher AE; Thijs l; Staessen JA; Dumitrascu DL; Forette F; Leonetti G; Nachev C; Tuomilehto J; Fagard RH
J Hypertens : 2 (2002)

"Nachev C" - Selaus tekijän mukaan Kansanterveyslaitos KTL

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion ﻿

Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension ﻿

Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project ﻿

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial ﻿

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension ﻿

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-up Study (SYST-EUR 2) ﻿

Hypertension in the very elderly trial (HYVET) protocol for the main trial ﻿

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial ﻿

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension ﻿

Predictive value of clinic and ambulatory heart rate for mortality in elderly subject with systolic hypertension ﻿

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension ﻿

Results of the pilot study for the hypertension in the very elderly trial ﻿

Subgroup and Pre-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly ﻿

Systolic blood pressure variablilty as a risk factor for stroke adn cardiovascular mortality in the elderly hypertensive population ﻿

Systolic hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress ﻿

Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trial ﻿

Withdrawal from treatment in the SYST-EUR Trial ﻿